Skip to evidence report

FIB.adventitial.complement_angiocrine: Studies — page 12

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 5,164 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 11,001–12,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for FIB.adventitial.complement_angiocrine
#Trait / studyIndividual trait IDMean IC score
11001Primary biliary cholangitisGCST0031299.82e-05
11002Average diameter for VLDL particlesGCST900930029.81e-05
11003SLAMF1 levelsGCST902748359.81e-05
11004PsoriasisGCST904681479.79e-05
11005ASGR1 levelsGCST904683759.76e-05
11006ICAM3/NOTCH1 ratioGCST903151229.75e-05
11007CRYBB1 levelsGCST904688749.72e-05
11008Arthropathies in other diseases classified elsewhereFING000001089.71e-05
11009Linoleic acid levelsGCST905020129.67e-05
11010Cholesteryl Esters in Medium LDLGCST904987389.64e-05
11011CD48/CRTAM ratioGCST903138399.64e-05
11012Phospholipids in large LDLGCST904980499.59e-05
11013Burger likingGCST900947159.59e-05
11014IDP T1 FAST ROIs R postcent gyrusGCST900024849.53e-05
11015Triglyceride to HDL cholesterol ratioGCST902959539.52e-05
11016CD40/TNFRSF14 ratioGCST903138309.49e-05
11017Body-mass index, inverse-rank normalizedFING000002229.44e-05
11018Fasting plasma glucoseGCST902977879.44e-05
11019PLXNA4/USP8 ratioGCST903156909.36e-05
11020PALM3 levelsGCST904701539.31e-05
11021Cholesterol levels in very large VLDLGCST905005179.26e-05
11022Triglycerides to total lipids in very large HDL percentage (UKB data field 23633)GCST902697309.23e-05
11023SIGLEC1/SSC5D ratioGCST903158449.21e-05
11024Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST905025559.19e-05
11025Takes medication for high cholesterol?GCST904752089.18e-05
11026Never eat wheat vs no eggs, dairy, wheat or sugar restrictions (UKB data field 6144)GCST901329319.18e-05
11027Kela-code for severe mental illnessFING000007079.17e-05
11028CD74/JAM2 ratioGCST903138939.07e-05
11029SKAP1 levelsGCST904706459.06e-05
11030Mineral and other dietary supplements - None of the above | MedicationUKBB000004749.06e-05
11031Triglycerides to Total Lipids in IDL percentageGCST904976769.04e-05
11032rfMRI connectivity (ICA25 edge 101)GCST900047449.03e-05
11033Hypothyroidism (PheCode 244)GCST904756479.02e-05
11034Total lipids in very large HDLGCST905004239.01e-05
11035GDF15 levelsGCST904693218.98e-05
11036Total lipids in medium VLDLGCST904989948.95e-05
11037Concentration of IDL particlesGCST904976068.95e-05
11038ITGB5/SIAE ratioGCST903152348.90e-05
11039IGF2R levelsGCST904695268.89e-05
11040ECHS1 levelsGCST904690638.89e-05
11041Triglycerides in medium LDLGCST904988708.87e-05
11042Lymphoid neoplasms (B-cell phenocluster)GCST906247368.86e-05
11043APP levelsGCST904683448.81e-05
11044Polyunsaturated fatty acids to total fatty acids percentageGCST905026338.79e-05
11045CDC37/SNAP29 ratioGCST903139358.75e-05
11046Cholesteryl ester levels in very small VLDLGCST900930308.72e-05
11047CPB1/PRSS2 ratioGCST903142118.70e-05
11048Cholesteryl esters to total lipids ratio in medium LDLGCST900929078.67e-05
11049BAX/MAX ratioGCST903134668.65e-05
11050ARHGEF12/IRAK4 ratioGCST903133508.64e-05
11051Triglycerides in HDLGCST904974678.61e-05
11052SCARF1 levelsGCST904705368.60e-05
11053aseg rh number HolesBeforeFixingGCST900026478.59e-05
11054TYRP1 levelsGCST904709988.57e-05
11055Phospholipids in small LDLGCST904996818.56e-05
11056Omega-3 fatty acid levelsGCST905024248.54e-05
11057Triglycerides to total lipids ratio in large LDLGCST900928678.52e-05
11058Cholesterol, totalGCST0022218.49e-05
11059Pregnenediol sulfate (C21H34O5S) levelsGCST901998618.48e-05
11060HYOU1/RARRES2 ratioGCST903151038.43e-05
11061WFIKKN2 levelsGCST904710778.43e-05
11062Miserableness | Mental healthUKBB000004788.42e-05
11063NOTCH1/SEMA7A ratioGCST903155458.42e-05
11064CPA1/CTRB1 ratioGCST903142038.38e-05
11065lymphocyte (absolute count, mean, inv-norm transformed)GCST904754268.36e-05
11066Pain in limbFING000011388.35e-05
11067TFF2 levelsGCST904708368.34e-05
11068Phospholipid levels in small VLDLGCST900929768.33e-05
11069PGLYRP1 levelsGCST904702198.31e-05
11070GLB1/GUSB ratioGCST903149318.29e-05
11071NUDT5/RWDD1 ratioGCST903155808.28e-05
11072DSG3 levelsGCST904690438.27e-05
11073Number of days/week walked 10+ minutes | Physical activityUKBB000005358.25e-05
11074Prostate cancerGCST0060858.25e-05
11075Hyperparathyroidism (PheCode 252.1)GCST904756938.23e-05
11076FGFBP1 levelsGCST904692308.22e-05
11077Lichen ruber planus, wide definition including periferal and oral lichen planusFING000007228.20e-05
11078Phospholipids in medium LDLGCST904988318.16e-05
11079Thyroid peroxidase antibody positivity with euthyroid in pregnancyGCST904352038.16e-05
11080CancerGCST900860528.15e-05
11081Asthma-related pneumoniaFING000001198.15e-05
11082Autoimmune hyperthyroidismFING000001348.14e-05
11083Scar conditions and fibrosis of skin (PheCode 701.2)GCST904761988.10e-05
11084Abnormal results of function study of liver (PheCode 573.7)GCST904760978.09e-05
11085Cholesterol to Total Lipids in Very Large HDL percentageGCST905003338.06e-05
11086FKBP4/RWDD1 ratioGCST903148408.05e-05
11087Percentage of trisyalated structures in total plasma glycans (GP97)GCST906685418.05e-05
11088MMP9/OSM ratioGCST903154688.05e-05
11089CDCP1 levelsGCST904686678.04e-05
11090KLK10 levelsGCST904696968.03e-05
11091Free cholesterol to total lipids in small LDL percentage (UKB data field 23627)GCST902697248.02e-05
11092Skin cancerGCST904751897.99e-05
11093Mean platelet thrombocyte volume (UKB data field 30100)GCST904680877.93e-05
11094COPD/asthma/ILD related infectionsFING000003537.92e-05
11095Omega-6 fatty acid levelsGCST905021017.90e-05
11096Basophil countGCST900022937.89e-05
11097HAVCR2/TNFRSF1B ratioGCST903150307.89e-05
11098Eosinophill count | Blood countUKBB000002067.89e-05
11099GLB1 levelsGCST904693557.85e-05
11100Triglycerides to total lipids ratio in small HDLGCST900929557.81e-05
11101Cholesterol to total lipids ratio in very small VLDLGCST900930297.80e-05
11102RETN/RNASET2 ratioGCST903157687.79e-05
11103HGFAC levelsGCST904694487.79e-05
11104Number of sexual partners in opposite-sex sexual behaviorGCST900264817.78e-05
11105DNAJB1/PPME1 ratioGCST903145107.74e-05
11106Androstenediol (3beta,17beta) disulfate (2) levelsGCST901998517.68e-05
11107F2R/TMSB10 ratioGCST903147387.60e-05
11108B2M levelsGCST904684097.59e-05
11109DDC levelsGCST904689677.59e-05
11110Eosinophill percentage (UKB data field 30210)GCST904680697.58e-05
11111Crohn's disease of large intestineFING000003687.56e-05
11112SIGLEC10 levelsGCST904706307.55e-05
11113VWC2 levelsGCST904710647.54e-05
11114ANXA4/FADD ratioGCST903132917.53e-05
11115Cholesteryl Esters to Total Lipids in Medium LDL percentageGCST904987587.51e-05
11116MASP1 levelsGCST904698637.51e-05
11117Concentration of small LDL particlesGCST900929637.47e-05
11118FXN/TRIAP1 ratioGCST903148997.45e-05
11119Cholesterol to total lipids ratio in very large VLDLGCST900930177.43e-05
11120FAM3B/GUCA2A ratioGCST903147797.43e-05
11121Whole body fat mass (UKB data field 23100)GCST904281217.41e-05
11122Cholesteryl Esters in LDLGCST904983747.41e-05
11123Principal component-derived dietary pattern 13GCST901330187.40e-05
11124Phospholipids in medium VLDLGCST904990247.38e-05
11125Triglycerides in small LDLGCST904997227.34e-05
11126Cholesterol in Small LDLGCST904995557.34e-05
11127Participation in an health questionnaire (not invited vs invited)GCST900127947.32e-05
11128Clinical LDL cholesterol levelsGCST904972197.30e-05
11129Total lipids in very large VLDLGCST905006147.29e-05
11130Cholesteryl ester levels in large VLDLGCST900928707.23e-05
11131Urine betaine levels in chronic kidney diseaseGCST902648597.20e-05
11132Lymphocyte percentage (UKB data field 30180)GCST904680837.20e-05
11133Monounsaturated fatty acids to total fatty acids percentageGCST905023737.18e-05
11134Fluid intelligence score (baseline)GCST905658427.18e-05
11135NRP2 levelsGCST904700867.16e-05
11136BTN2A1/SIGLEC1 ratioGCST903135487.14e-05
11137Hyperlipidemia (PheCode 272.1)GCST904757187.13e-05
11138Free cholesterol in large LDLGCST904979877.12e-05
11139Phospholipids to Total Lipids in Medium VLDL percentageGCST904990437.11e-05
11140Triglyceride levels in medium LDLGCST900929147.05e-05
11141Free cholesterol in IDLGCST904975617.05e-05
11142AKT1S1/FHIT ratioGCST903132287.05e-05
11143KLRF1 levelsGCST904697127.03e-05
11144Triglycerides to total lipids in medium LDL percentage (UKB data field 23623)GCST902697206.98e-05
11145CCL5 levelsGCST904685846.96e-05
11146ADGRE2/IFNGR1 ratioGCST903131776.95e-05
11147Clonal haematopoiesis of indeterminate potential (DNMT3A mutation)GCST901652716.94e-05
11148Total lipids in medium VLDLGCST904990046.88e-05
11149CCL5/SELP ratioGCST903137056.87e-05
11150Sodium (mean, inv-norm transformed)GCST904763956.86e-05
11151Cholesteryl esters in very large VLDLGCST905005566.78e-05
11152Phospholipids to Total Lipids in IDL percentageGCST904976426.78e-05
11153Prostate cancerGCST904281176.76e-05
11154Phospholipids in small LDLGCST904996736.74e-05
11155METAP2/PFKFB2 ratioGCST903154316.72e-05
11156Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST905021476.72e-05
11157Volume of right cortical nucleusGCST904750336.71e-05
11158LDL cholesterolGCST0022226.70e-05
11159red cell diameter width (RDW, minimum, inv-norm transformed)GCST904763656.69e-05
11160Phospholipid levels in very small VLDLGCST900930366.68e-05
11161Ulcerative colitis (strict) with PSCFING000013896.65e-05
11162VEGFB levelsGCST904710356.63e-05
11163NAGA levelsGCST904699946.63e-05
11164Triglycerides in small LDL (UKB data field 23550)GCST902696476.61e-05
11165Systemic lupus erythematosusGCST900118666.59e-05
11166LAG3 levelsGCST904697276.53e-05
11167CLEC1B/SORT1 ratioGCST903141046.53e-05
11168Free cholesterol to total lipids ratio in large LDLGCST900928616.52e-05
11169Cholesteryl esters to total lipids in small HDL percentage (UKB data field 23646)GCST902697436.52e-05
11170FOLR2/THY1 ratioGCST903148676.47e-05
11171Non-oily fish consumptionGCST901329946.47e-05
11172IL22 levelsGCST904695826.45e-05
11173Tryptophan betaine levelsGCST901998196.42e-05
11174Chronic nephritic syndromeFING000002956.41e-05
11175Eosinophill count (UKB data field 30150)GCST904680686.40e-05
11176OSM/TGFA ratioGCST903155906.39e-05
11177DTI TBSS MD Posterior limb of internal capsule RGCST903845906.36e-05
11178CCL24 levelsGCST904685766.33e-05
11179Cholesterol in Large VLDLGCST904981236.30e-05
11180Aspartate aminotransferase levels (UKB data field 30650)GCST904680636.27e-05
11181Rheumatoid arthritisGCST901322246.25e-05
11182Total fatty acids levels (UKB data field 23442)GCST902695396.24e-05
11183PIGR levelsGCST904702326.21e-05
11184Triglyceride levels in LDLGCST900928906.21e-05
11185Polyunsaturated fatty acid levelsGCST905021406.21e-05
11186white blood cell count (WBC, maximum, inv-norm transformed)GCST904764516.19e-05
11187CPB2 levelsGCST904688406.18e-05
11188TNFSF8 levelsGCST904709236.18e-05
11189Eosinophil percentage of white cellsGCST900023826.14e-05
11190L1CAM/SEZ6L ratioGCST903152666.12e-05
11191BTC levelsGCST904684766.09e-05
11192Triglyceride levels in large VLDLGCST900928786.05e-05
11193Disorders of lipid metabolism (PheCode 272)GCST904757156.01e-05
11194EPHA4 levelsGCST904691316.00e-05
11195Concentration of medium VLDL particlesGCST900929235.96e-05
11196Apples likingGCST900946915.94e-05
11197Triglycerides in small HDL (UKB data field 23578)GCST902696755.94e-05
11198Polyunsaturated fatty acid levelsGCST904992665.94e-05
11199Linoleic acid to total fatty acids percentageGCST905023215.91e-05
11200CRNN levelsGCST904688695.91e-05
11201Rheumatoid arthritisFING000012675.91e-05
11202aparc-Desikan lh volume precuneusGCST900027925.89e-05
11203Cholesteryl Esters to Total Lipids in Very Large HDL percentageGCST905003735.86e-05
11204PTP4A3 levelsGCST904703755.86e-05
11205C9 levelsGCST904685055.84e-05
11206Cholesteryl Esters to Total Lipids in IDL percentageGCST904975495.84e-05
11207Mineral and other dietary supplements - Fish oil (including cod liver oil) | MedicationUKBB000004725.83e-05
11208Thyrotoxicosis with diffuse goitreFING000013615.82e-05
11209APOB levelsUKBB000000415.82e-05
11210HyperthyroidismGCST903193195.80e-05
11211Cholesteryl esters to total lipids ratio in very large VLDLGCST900930195.77e-05
11212LAYN/TNFRSF4 ratioGCST903152915.77e-05
11213Cholesterol levels in very large VLDLGCST900930165.74e-05
11214Phospholipids to total lipids ratio in large HDLGCST900928535.74e-05
11215OBP2B levelsGCST904701135.70e-05
11216mean corpuscular hemoglobin concentration (MCHC, maximum, inv-norm transformed)GCST904754545.69e-05
11217Triglycerides to Total Lipids in Very Small VLDL percentageGCST905008865.69e-05
11218Polyunsaturated fatty acid levelsGCST905026185.68e-05
11219Physical activityGCST900933245.67e-05
11220Glycine levelsGCST904973155.67e-05
11221MEP1B levelsGCST904698885.67e-05
11222Aniseed likingGCST900946895.66e-05
11223Docosahexaenoic acid to total fatty acids percentageGCST904972685.66e-05
11224Lymphocyte countGCST900023165.66e-05
11225CALCOCO1/CASP3 ratioGCST903135965.64e-05
11226Cholesteryl esters to total lipids ratio in large VLDLGCST900928715.63e-05
11227Saturated fatty acids to total fatty acids percentageGCST905026845.62e-05
11228Psoriasis (PheCode 696.4)GCST904761875.62e-05
11229AmygNuclei rh volume Lateral-nucleusGCST900026585.62e-05
11230Phospholipids in LDLGCST904984325.61e-05
11231Cholesteryl ester levels in chylomicrons and extremely large VLDLGCST905009495.60e-05
11232Cholesteryl esters in medium LDL (UKB data field 23541)GCST902696385.56e-05
11233Seropositive rheumatoid arthritis, strict definitionFING000012975.56e-05
11234Educational attainmentGCST0034965.55e-05
11235EFNA4/VWC2 ratioGCST903146075.54e-05
11236Principal component-derived dietary pattern 29GCST901330345.54e-05
11237Monounsaturated fatty acid levelsGCST904990945.53e-05
11238CST5 levelsGCST904688955.51e-05
11239LBR/LGALS8 ratioGCST903152945.51e-05
11240FRZB levelsGCST904692695.50e-05
11241Triglycerides to Total Lipids in Large LDL percentageGCST904980925.47e-05
11242S100A4/SNAP29 ratioGCST903158015.47e-05
11243Prostate cancerGCST902747145.44e-05
11244Triglyceride levels in very large VLDLGCST900930265.44e-05
11245Eosinophil countGCST0046065.43e-05
11246FCRL6 levelsGCST904692095.40e-05
11247CD27/DLL1 ratioGCST903137715.40e-05
11248Eosinophill percentage | Blood countUKBB000002075.40e-05
11249Total lipid levels in chylomicrons and extremely large VLDLGCST900930465.38e-05
11250DTI autoptx FA ptr l tractGCST903851315.38e-05
11251Cerebrospinal fluid beta-hydroxyisovaleroylcarnitine levelsGCST903180135.37e-05
11252GPRC5C levelsGCST904693985.36e-05
11253CRHBP levelsGCST904688605.32e-05
11254Eosinophil countGCST900023815.31e-05
11255Lymphocyte count | Blood countUKBB000004115.30e-05
11256Orotidine levelsGCST902006815.29e-05
11257Citrate levelsGCST900928135.29e-05
11258Phospholipids to total lipids in small LDL percentage (UKB data field 23624)GCST902697215.27e-05
11259S100A11/S100A12 ratioGCST903157985.26e-05
11260MRC1 levelsGCST904699395.25e-05
11261Triglycerides to Total Lipids in Medium HDL percentageGCST904986825.21e-05
11262First line medication for Crohn's diseaseFING000005445.21e-05
11263DTI TBSS L1 Anterior corona radiata RGCST903844505.20e-05
11264TCL1A levelsGCST904708175.19e-05
11265MMP8/OLR1 ratioGCST903154645.19e-05
11266Triglycerides in LDLGCST904984695.18e-05
11267Omega-6 fatty acids to total fatty acids percentage (UKB data field 23452)GCST902695495.18e-05
11268Age at first birthGCST900000485.17e-05
11269TriglyceridesGCST0007585.16e-05
11270CD99L2/CPM ratioGCST903139255.16e-05
11271Remnant cholesterol (non-HDL, non-LDL -cholesterol)GCST900929435.13e-05
11272Triglycerides to total lipids ratio in very large HDLGCST900930155.12e-05
11273TST levelsGCST904709825.09e-05
11274Triglyceride to HDL cholesterol ratioGCST902959505.09e-05
11275Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)GCST901322275.08e-05
11276Alcohol likingGCST900946885.07e-05
11277SIGLEC6 levelsGCST904706345.06e-05
11278ITGB2 levelsGCST904696445.06e-05
11279ATOX1/TMSB10 ratioGCST903133775.02e-05
11280Linoleic acid levelsGCST905020105.01e-05
11281Eosinophil countGCST900022995.01e-05
11282Total lipid levels in very large VLDLGCST900930224.99e-05
11283OLFM4 levelsGCST904701214.99e-05
11284Triglyceride levels in large LDLGCST900928664.99e-05
11285GP1BA/HBEGF ratioGCST903149564.97e-05
11286GYS1/PPP1R2 ratioGCST903150014.97e-05
11287Phospholipid levels in medium VLDLGCST900929244.96e-05
11288EPHB6/VWC2 ratioGCST903146834.96e-05
11289LSP1 levelsGCST904698114.94e-05
11290Cholesterol to Total Lipids in Large LDL percentageGCST904979384.87e-05
11291DAG1/HBEGF ratioGCST903143764.87e-05
11292TNFRSF10C levelsGCST904709014.85e-05
11293Alzheimer's disease (MTAG)GCST904490604.84e-05
11294STC2 levelsGCST904707624.81e-05
11295HippSubfield lh volume GC-ML-DG-headGCST900026794.81e-05
11296ThyrotoxicosisFING000013604.81e-05
11297CXCL6 levelsGCST904689334.81e-05
11298Saturated fatty acids levelsGCST904999504.81e-05
11299Paracetamol of NSAID medicationFING000011454.77e-05
11300white blood cell count (WBC, mean, inv-norm transformed)GCST904764544.76e-05
11301Eosinophil percentage of white cellsGCST0046004.75e-05
11302APOB levelsGCST900928094.74e-05
11303ITIH4 levelsGCST904696514.73e-05
11304TPI1 levelsGCST900886594.72e-05
11305CA3/HMBS ratioGCST903135844.71e-05
11306Psoriasis and related disorder (PheCode 696)GCST904761864.70e-05
11307CD99L2/RARRES2 ratioGCST903139274.67e-05
11308SarcoidosisFING000012754.67e-05
11309Docosahexaenoic acid levelsGCST905022544.67e-05
11310NADK/PXN ratioGCST903155124.66e-05
11311Physical activity (standard GWA)GCST902672924.65e-05
11312Cholesteryl Esters to Total Lipids in Small LDL percentageGCST904995954.64e-05
11313Apple juice likingGCST900946904.64e-05
11314C1QA levelsGCST904684854.63e-05
11315SORT1/ST6GAL1 ratioGCST903158694.60e-05
11316Number of diet questionnaires completed | Diet questionnaire performanceUKBB000005364.58e-05
11317Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905010914.56e-05
11318GRPEL1/MME ratioGCST903149924.55e-05
11319Total phospholipid levels in lipoprotein particlesGCST905001244.54e-05
11320PSRC1 levelsGCST904703654.51e-05
11321Lymphocyte countGCST900023884.49e-05
11322Phospholipid levels in very large VLDLGCST900930244.48e-05
11323Triglycerides to Total Lipids in Small VLDL percentageGCST904999224.45e-05
11324RNF43 levelsGCST904224824.43e-05
11325Average total household income before tax | HouseholdUKBB000000814.43e-05
11326GFRA2/IL12A_IL12B ratioGCST903149254.41e-05
11327Concentration of small LDL particlesGCST904996604.40e-05
11328Triglycerides to total lipids ratio in IDLGCST900928424.40e-05
11329Free cholesterol levels in very large VLDLGCST900930204.39e-05
11330Triglycerides to Total Lipids in Very Large VLDL percentageGCST905006954.38e-05
11331FCAR/LY96 ratioGCST903147884.37e-05
11332Lymphocyte countGCST0046274.36e-05
11333APBB1IP/NADK ratioGCST903132984.34e-05
113341-stearoyl-2-oleoyl-GPS (18:0/18:1) levelsGCST901996524.33e-05
11335Cholesteryl Esters in Small LDLGCST904995784.31e-05
11336Basophil percentage of granulocytesGCST0046344.29e-05
11337Cholesterol in Large VLDLGCST904981194.27e-05
11338Visceral adipose tissue normalizedGCST902673584.25e-05
11339Neutrophils and lymphocytes in blood (confirmatory factor analysis Factor 35)GCST903093694.23e-05
11340Average diameter for LDL particlesGCST900928894.22e-05
11341Omega-6 fatty acids to total fatty acids percentageGCST905025444.20e-05
11342IL18 levelsGCST904284114.20e-05
11343CLEC1B/HBEGF ratioGCST903140924.16e-05
11344Monounsaturated fatty acid levelsGCST905023464.13e-05
11345Total triglycerides levelsGCST905001264.11e-05
11346Omega-6 fatty acids to total fatty acids percentageGCST904992104.10e-05
11347GFER/TRIAP1 ratioGCST903149214.10e-05
11348Lymphocyte count (UKB data field 30120)GCST904680824.10e-05
11349Psoriasis vulgaris (PheCode 696.41)GCST904761904.09e-05
11350Phosphatidylcholine levelsGCST904992404.09e-05
11351Curry likingGCST900947504.09e-05
11352CCN2/ENO2 ratioGCST903137124.08e-05
11353NUCB2/RSPO3 ratioGCST903155754.08e-05
11354ENPP2 levelsGCST904691154.05e-05
11355BACH1/DIABLO ratioGCST903134374.02e-05
11356Hypercholesterolemia | endocrine/metabolicUKBB000003324.02e-05
11357Linoleic acid to total fatty acids percentageGCST905020173.99e-05
11358Phospholipids to Total Lipids in Large LDL percentageGCST904980713.98e-05
11359Family relationship satisfaction | Mental healthUKBB000002383.97e-05
11360Omega-6 fatty acid levelsGCST905021033.97e-05
11361DermatitisFING000004013.97e-05
11362Triglycerides in LDLGCST904984723.96e-05
11363Eosinophil countGCST900022983.96e-05
11364TSC1 levelsGCST904709723.94e-05
11365Autoimmune diseasesFING000001313.93e-05
11366mean corpuscular volume (MCV, minimum, inv-norm transformed)GCST904754743.93e-05
11367Cholesteryl esters to total lipids in medium VLDL percentage (UKB data field 23596)GCST902696933.93e-05
11368Lymphocyte percentage of white cellsGCST900023893.92e-05
11369CD40LG levelsGCST904686323.92e-05
11370Prospective memory result | Prospective memoryUKBB000007133.91e-05
11371Triglycerides in IDL (UKB data field 23529)GCST902696263.90e-05
11372Concentration of medium LDL particlesGCST900929113.89e-05
11373FADD/PPP1R2 ratioGCST903147743.88e-05
11374LAYN/VWC2 ratioGCST903152933.88e-05
11375Chronic sinusitisFING000002983.87e-05
11376Other symptoms of respiratory system (PheCode 512)GCST904760393.87e-05
11377Triglycerides in VLDLGCST905003043.86e-05
11378Cholesteryl Esters to Total Lipids in Very Small VLDL percentageGCST905007543.86e-05
11379Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST904992873.84e-05
11380Reticulocyte percentage (UKB data field 30240)GCST904681013.82e-05
11381Concentration of chylomicrons and extremely large VLDL particlesGCST900930473.81e-05
11382Own or rent accommodation lived in - Own outright (by you or someone in your household) | HouseholdUKBB000006233.81e-05
11383PTPRM/SELE ratioGCST903157533.80e-05
11384Dementia, including avohilmoFING000003953.79e-05
11385LCN2/PGLYRP1 ratioGCST903153063.78e-05
11386Attendance/disability/mobility allowance - Disability living allowance | Other sociodemographic factorsUKBB000000583.77e-05
11387Concentration of small HDL particlesGCST900929513.76e-05
11388IL15/KLRD1 ratioGCST903151493.74e-05
11389Biological Sibling: AsthmaGCST904763723.72e-05
11390Triglycerides in very large HDLGCST905004823.72e-05
11391Concentration of medium LDL particlesGCST904988193.72e-05
11392Free cholesterol in medium HDLGCST904985633.71e-05
11393Saturated fatty acids levelsGCST905026593.69e-05
11394Deaf mutism, not elsewhere classifiedFING000003783.65e-05
11395CRTAP levelsGCST904688723.64e-05
11396CEACAM6 levelsGCST904686973.60e-05
11397Concentration of small VLDL particlesGCST904998563.58e-05
11398Concentration of very large VLDL particlesGCST900930233.55e-05
11399ERMAP levelsGCST904691473.54e-05
11400Sum eosinophil basophil countsGCST0046243.50e-05
11401GOPC/IRAK4 ratioGCST903149543.50e-05
11402Triglyceride levels in very large HDLGCST901326363.50e-05
11403ITGB1BP2 levelsGCST900120583.49e-05
11404Cholesteryl Esters in Large HDLGCST904977533.49e-05
11405Free cholesterol in large HDLGCST904977863.47e-05
11406Phospholipids to total lipids in small VLDL percentage (UKB data field 23599)GCST902696963.46e-05
11407Linoleic acid to total fatty acids percentageGCST904983213.45e-05
11408Asthma (more control exclusions)FING000001133.45e-05
11409RNF41/WWP2 ratioGCST903157823.43e-05
11410GZMA levelsGCST904694233.41e-05
11411Phospholipids to Total Lipids in Small LDL percentageGCST904997003.39e-05
11412Hypothyroidism, strict autoimmuneFING000006563.37e-05
11413Cholesterol levels in large VLDLGCST900928683.37e-05
11414PLA2G4A/SDC4 ratioGCST903156683.37e-05
11415Omega-3 fatty acid levelsGCST905024253.36e-05
11416Total fatty acid levelsGCST905022203.35e-05
11417Total cholesterol minus HDL-C levelsGCST904991293.34e-05
11418Cholesterol in Small HDLGCST904993583.32e-05
11419Eosinophil percentage of granulocytesGCST0046173.31e-05
11420Anorexia (incl.atypical)FING000000933.30e-05
11421CLEC4G/SEMA3F ratioGCST903141233.29e-05
11422CD99/RELT ratioGCST903139303.29e-05
11423HypertensionGCST900860923.28e-05
11424IGSF8 levelsGCST904695403.28e-05
11425CFHR2 levelsGCST904687263.27e-05
11426Saturated fatty acids levelsGCST905021863.27e-05
11427Free cholesterol in small LDLGCST904996203.26e-05
11428TriglyceridesGCST0022163.26e-05
11429Comfortable retirement (confirmatory factor analysis Factor 29)GCST903093633.25e-05
11430Cholesteryl Esters in Small LDLGCST904995863.24e-05
11431Triglyceride levels in VLDLGCST900930033.24e-05
11432Frequency of solarium/sunlamp use | Sun exposureUKBB000002653.24e-05
11433Glycoprotein acetyls levels (UKB data field 23480)GCST902695773.23e-05
11434PM: initial answer - Orange circle| Prospective memoryUKBB000006523.22e-05
11435Plasma X-24947 levels in chronic kidney diseaseGCST902668163.22e-05
11436Total Lipids in Medium LDLGCST904988063.22e-05
11437COL2A1 levelsGCST904688163.21e-05
11438GP5 levelsGCST904693833.20e-05
11439Psoriasis vulgarisFING000012243.19e-05
11440Cholesteryl Esters to Total Lipids in Large LDL percentageGCST904979673.19e-05
11441Graves' disease (PheCode 242.1)GCST904756443.19e-05
11442ADH1B levelsGCST904682433.18e-05
11443Blood cell traits latent factor 18 (platelet)GCST905592603.16e-05
11444Hypothyroidism NOS (PheCode 244.4)GCST904756533.15e-05
11445Total lipids in small HDLGCST904994433.15e-05
11446ERBB4/NELL1 ratioGCST903146913.14e-05
11447MSRA/PRDX5 ratioGCST903154973.14e-05
11448CRISP2 levelsGCST904688653.13e-05
11449Broad bean likingGCST900947113.12e-05
11450mean corpuscular volume (MCV, mean, inv-norm transformed)GCST904754703.10e-05
11451Alkylphosphatidylcholine (O-34:1) levelsGCST900249253.08e-05
11452Concentration of VLDL particlesGCST905002463.08e-05
11453Total fatty acid levelsGCST905022123.08e-05
11454Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)FING000008463.08e-05
11455ICAM2/SELE ratioGCST903151203.07e-05
11456DementiaFING000003913.06e-05
11457RETN levelsGCST900120343.05e-05
11458mean corpuscular hemoglobin concentration (MCHC, mean, inv-norm transformed)GCST904754583.05e-05
11459Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009583.05e-05
11460CD5 levelsGCST904686413.04e-05
11461ARSA levelsGCST904683683.03e-05
11462CFHR5 levelsGCST904687283.02e-05
11463CLEC4M levelsGCST904687753.02e-05
11464SDC4/SMAD1 ratioGCST903158203.01e-05
11465Cholesterol to Total Lipids in IDL percentageGCST904975183.00e-05
11466Concentration of small HDL particles (UKB data field 23572)GCST902696693.00e-05
11467Noninfective enteritis and colitisFING000008812.99e-05
11468Phospholipid levels in large VLDLGCST900928762.99e-05
11469Polyunsaturated fatty acids to total fatty acids percentageGCST904993022.99e-05
11470Non-oily fish intake | DietUKBB000005252.98e-05
11471Takes medication for Sleep apnea?GCST904752582.98e-05
11472Total lipid levels in large VLDLGCST900928742.95e-05
11473TNF/TNFRSF1B ratioGCST903159422.95e-05
11474CA14 levelsGCST904685092.94e-05
11475Phospholipid levels in chylomicrons and extremely large VLDLGCST900930482.92e-05
11476ACHE levelsGCST904681992.92e-05
11477CSF1R levelsGCST904688802.90e-05
11478CEACAM8/MMP9 ratioGCST903140022.89e-05
11479CRADD/MAP4K5 ratioGCST903142402.89e-05
11480Sicca syndrome [Sjögren]FING000013042.87e-05
11481CRTAM levelsGCST904688712.86e-05
11482Total lipid levels in chylomicrons and extremely large VLDLGCST905009942.85e-05
11483LAT/SERPINE1 ratioGCST903152872.84e-05
11484Illnesses of mother: Alzheimer's disease/dementia (UKB data field 20110_10)GCST900426782.84e-05
11485CRISP3 levelsGCST904688662.82e-05
11486Triglyceride levels in large HDLGCST900928542.82e-05
11487Ankylosing spondylitisFING000000892.82e-05
11488LifespanGCST905518852.82e-05
11489Triglyceride to phosphoglyceride ratioGCST904999922.79e-05
11490Spicy food likingGCST900948462.79e-05
11491Basophil percentage of white cells varianceGCST905656882.79e-05
11492NUCB2/TRIAP1 ratioGCST903155772.77e-05
11493FOXO1/IRAK4 ratioGCST903148702.76e-05
11494Platelet distribution widthGCST0046162.74e-05
11495Free Cholesterol to Total Lipids in Small VLDL percentageGCST904998322.74e-05
11496Metabolic syndromeGCST904444872.74e-05
11497HBEGF/PLXNA4 ratioGCST903150362.73e-05
11498Liver condition (ex. cirrhosis)GCST904752702.71e-05
11499Triglycerides to Total Lipids in Small LDL percentageGCST904997402.71e-05
11500LRG1 levelsGCST904697932.70e-05
11501CA4/SELE ratioGCST903135872.70e-05
11502Prescriptions - thyroid hormone | hormoneUKBB000007052.69e-05
11503Prescriptions - levothyroxine | thyroid hormoneUKBB000006872.69e-05
11504Abnormality of gait (PheCode 350.2)GCST904758412.68e-05
11505Triglycerides in large HDLGCST904978822.67e-05
11506Cholesterol in small HDL (UKB data field 23575)GCST902696722.67e-05
11507BSG levelsGCST904684722.65e-05
11508APOB levelsGCST904971372.65e-05
11509CPA2/ITGB7 ratioGCST903142072.64e-05
11510DTI TBSS L2 External capsule LGCST903845092.63e-05
11511High cholesterolGCST904681342.61e-05
11512Cereal type: Muesli (UKB data field 1468_4)GCST901329722.60e-05
11513CWC15 levelsGCST904689202.60e-05
11514IL18BP levelsGCST904695642.59e-05
11515Average diameter for VLDL particlesGCST905002902.59e-05
11516Use of hypnotics and sedativesFING000014112.59e-05
11517Psoriatic arthritisGCST902439562.57e-05
11518Free cholesterol to total lipids in small VLDL percentage (UKB data field 23602)GCST902696992.57e-05
11519Monounsaturated fatty acid levelsGCST905023632.57e-05
11520IL1RAP levelsGCST904695732.57e-05
11521Total lipids in small VLDLGCST904998402.57e-05
11522CD300C/FOLR2 ratioGCST903137872.56e-05
11523Monounsaturated fatty acid levelsGCST905023582.56e-05
11524AMOTL2 levelsGCST904682942.53e-05
11525Cholesterol, totalGCST0007602.53e-05
11526Cholesteryl Esters to Total Lipids in Medium LDL percentageGCST904987472.53e-05
11527FHIT/PARK7 ratioGCST903148212.52e-05
11528Omega-6 fatty acid levelsGCST905025022.50e-05
11529Concentration of large VLDL particlesGCST900928752.49e-05
11530Operative procedures - Total cholecystectomy NEC | Summary OperationsUKBB000005892.49e-05
11531WFDC12 levelsGCST904710732.48e-05
11532CD83 levelsGCST904686522.47e-05
11533Loneliness (standard GWA)GCST902672882.47e-05
11534Triglycerides to Total Lipids in Large LDL percentageGCST904981012.45e-05
11535Lymphoid neoplasms (somatic mutation group 2 phenocluster)GCST906247502.45e-05
11536Free cholesterol levels in large VLDLGCST900928722.45e-05
11537Total lipids in very small VLDLGCST905008132.44e-05
11538Physical activity (Total log acceleration 8pm-10pm)GCST900614192.43e-05
11539Qualifications - O levels/GCSEs or equivalent | EducationUKBB000007312.43e-05
11540AMBP/RARRES2 ratioGCST903132562.42e-05
11541Concentration of small VLDL particlesGCST900929752.42e-05
11542F11R/GP1BA ratioGCST903147222.42e-05
11543F-sweetened coffee drink liking (derived food-liking factor)GCST900948532.42e-05
11544Lymphoid neoplasmsGCST906247432.41e-05
11545Triglycerides to Total Lipids in Medium LDL percentageGCST904988812.41e-05
11546GP6/SCARF1 ratioGCST903149692.40e-05
11547CC2D1A/CRADD ratioGCST903136632.40e-05
11548Total cholesterol levelsGCST905000152.40e-05
11549LDL cholesterol levelsGCST904983462.37e-05
11550GGH levelsGCST904693352.36e-05
11551Docosahexaenoic acid to total fatty acids percentageGCST904972702.36e-05
11552Cholesterol levels (UKB data field 30690)GCST904680662.35e-05
11553CLEC6A levelsGCST904687772.34e-05
11554Triglycerides in very small VLDL (UKB data field 23522)GCST902696192.33e-05
11555OLR1/OSM ratioGCST903155832.33e-05
11556Mean corpuscular volumeGCST900023922.33e-05
11557Plasma 16a-hydroxy DHEA 3-sulfate levels in chronic kidney diseaseGCST902643282.32e-05
11558Monounsaturated fatty acids levels (UKB data field 23447)GCST902695442.31e-05
11559Symptoms concerning nutrition, metabolism, and development (PheCode 1002)GCST904755562.31e-05
11560IDP dMRI TBSS L1 Genu of corpus callosumGCST900040772.30e-05
11561OSCAR levelsGCST904701312.30e-05
11562Total esterified cholesterol levelsGCST905000362.30e-05
11563Free Cholesterol to Total Lipids in Large HDL percentageGCST904977902.29e-05
11564BCAM/NOTCH1 ratioGCST903134742.29e-05
11565Cholesterol | Blood biochemistryUKBB000001342.28e-05
11566Neutrophil percentage of white cellsGCST0046332.26e-05
11567Cancer of prostate (PheCode 185)GCST904755912.26e-05
11568Cereal type: Other (e.g. Cornflakes, Frosties) (UKB data field 1468_5)GCST901329732.25e-05
11569Total lipids in large LDLGCST904980112.24e-05
11570Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)FING000007772.23e-05
11571Monounsaturated fatty acids to total fatty acids percentageGCST905023842.23e-05
11572Triglycerides to total lipids ratio in large HDLGCST900928552.21e-05
11573HPCAL1/LAT ratioGCST903150722.20e-05
11574Triglycerides in medium LDL (UKB data field 23543)GCST902696402.20e-05
11575Ectopic pregnancyFING000004872.19e-05
11576neutrophil (fraction, minimum, inv-norm transformed)GCST904755412.19e-05
11577Peripheral or central vertigo (PheCode 386.2)GCST904759072.18e-05
11578CXCL16 levelsGCST904689282.18e-05
11579Triglycerides to total lipids ratio in very large VLDLGCST900930272.18e-05
11580Alkylphosphatidylcholine (O-34:1) levelsGCST900255512.18e-05
11581Free cholesterol to total lipids ratio in medium LDLGCST900929092.16e-05
11582Asthma (only as main-diagnosis) (more control exclusions)FING000001142.15e-05
11583F-wine liking (derived food-liking factor)GCST900948722.15e-05
11584Omega-6 fatty acids levelsGCST904991702.15e-05
11585Triglycerides to total lipids ratio in medium LDLGCST900929152.15e-05
11586Cooked vegetable intake | DietUKBB000001472.14e-05
11587Behenoyl dihydrosphingomyelin (d18:0/22:0) levelsGCST902000592.13e-05
11588PPP1R2/USP8 ratioGCST903157232.12e-05
11589Raw vegetable consumptionGCST901329782.12e-05
11590Cheese consumptionGCST901330002.10e-05
11591Treatment/medication code - levothyroxine sodium | MedicationsUKBB000008492.08e-05
11592Other (seronegative) rheumatoid arthritis, wideFING000009172.08e-05
11593Basal cell carcinoma (MTAG)GCST901374112.07e-05
11594CCL2 levelsGCST904685812.07e-05
11595SORT1/VSIR ratioGCST903158702.06e-05
11596Free cholesterol in small VLDLGCST904998082.06e-05
11597CD6 levelsGCST904686442.05e-05
11598F-dairy liking (derived food-liking factor)GCST900947512.05e-05
11599Shoulder lesionsFING000013032.04e-05
11600Free cholesterol levels in very large HDLGCST900930082.04e-05
11601Abdominal pain | symptomsUKBB000000032.04e-05
11602Total lipids in small HDL (UKB data field 23573)GCST902696702.03e-05
11603SLPI levelsGCST904260302.01e-05
11604EFNA4/TNFRSF9 ratioGCST903146062.00e-05
11605Cholesterol in Large LDLGCST904979192.00e-05
11606Omega-6 fatty acid levelsGCST905025181.98e-05
11607Oral glucose tolerance test-0hGCST902977881.97e-05
11608Degree of unsaturationGCST905027371.97e-05
11609Total free cholesterol levelsGCST905000631.97e-05
11610Non-albumin protein levelsUKBB000005031.97e-05
11611Water intake | DietUKBB000009061.95e-05
11612ICAM3/LY9 ratioGCST903151211.95e-05
11613Total lipid levels in lipoprotein particlesGCST900929891.94e-05
11614Crohn disease (strict definition, require KELA, min 2 HDR)FING000003661.93e-05
11615Triglyceride levels in medium VLDLGCST900929261.93e-05
11616PLB1 levelsGCST904702531.92e-05
11617PILRB levelsGCST904702371.91e-05
11618TinnitusGCST904482421.90e-05
11619VLDL cholesterol levelsGCST900929961.89e-05
11620CX3CL1/EPHB6 ratioGCST903143241.89e-05
11621Other hypothyroidism | Disorders of thyroid glandUKBB000006111.89e-05
11622Neutrophil percentage of granulocytesGCST0046231.87e-05
11623SPINT2 levelsGCST904707281.87e-05
11624Triglycerides to total lipids ratio in small LDLGCST900929671.86e-05
11625Concentration of very small VLDL particlesGCST900930351.85e-05
11626ALCAM/ICAM3 ratioGCST903132371.85e-05
11627F11R/PLXNA4 ratioGCST903147241.85e-05
11628Alanine levelsGCST0036661.84e-05
11629Hypothyroidism NOS | endocrine/metabolicUKBB000003361.83e-05
11630Omega-6 fatty acids to total fatty acids percentageGCST905021291.82e-05
11631Cholesterol to total lipids in medium VLDL percentage (UKB data field 23595)GCST902696921.79e-05
11632FCER2/TCL1A ratioGCST903147901.79e-05
11633Sleep durationGCST0038391.79e-05
11634Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009201.79e-05
11635Cholesteryl esters to total lipids ratio in large LDLGCST900928591.78e-05
11636Total fatty acid levelsGCST905027111.78e-05
11637Coeliac diseaseFING000003121.77e-05
11638Age when finished full-time education (weighted GWA)GCST902672811.75e-05
11639Atopic dermatitisFING000001251.75e-05
11640Triglycerides in medium HDL (UKB data field 23571)GCST902696681.75e-05
11641CD27/NBL1 ratioGCST903137741.74e-05
11642Free cholesterol levels in very small VLDLGCST900930321.74e-05
11643Ratio of linoleic acid to total fatty acidsGCST900928811.70e-05
11644Lymphoid neoplasms (drug group 1 phenocluster)GCST906247401.70e-05
11645Citrate levelsGCST904972061.69e-05
11646Cholesterol to Total Lipids in Small LDL percentageGCST904995691.68e-05
11647Free Cholesterol to Total Lipids in Medium VLDL percentageGCST904989881.67e-05
11648HBEGF levelsGCST904694331.67e-05
11649Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)FING000011431.66e-05
11650Cholesteryl esters to total lipids ratio in medium VLDLGCST900929191.66e-05
11651GGT1 levelsGCST904693361.65e-05
11652SCGB3A1 levelsGCST904705421.65e-05
11653Mean platelet volumeGCST0045991.65e-05
11654Total lipid levels in very small VLDLGCST900930341.63e-05
11655Crohn's disease of small intestineFING000003691.62e-05
11656Non-cancer illness code, self-reported - gout | Medical conditionsUKBB000005121.62e-05
11657CA13/QDPR ratioGCST903135641.62e-05
11658DPP6/NELL2 ratioGCST903145411.60e-05
11659Hypothyroidism | endocrine/metabolicUKBB000003351.59e-05
11660Cholesterol to Total Lipids in Very Small VLDL percentageGCST905007161.59e-05
11661Concentration of VLDL particlesGCST900930001.58e-05
11662ROR1/TNFRSF21 ratioGCST903157871.57e-05
11663Cholesterol to total lipids ratio in medium LDLGCST900929051.56e-05
11664Polyunsaturated fatty acid levelsGCST905021341.56e-05
11665Free cholesterol to total lipids ratio in large HDLGCST900928491.56e-05
11666ENG/TNFRSF10C ratioGCST903146501.56e-05
11667Free cholesterol levels in chylomicrons and extremely large VLDLGCST900930441.55e-05
11668CALCOCO1/PFKFB2 ratioGCST903136081.55e-05
11669Cholesterol to total lipids ratio in large HDLGCST900928451.55e-05
11670MMP9 levelsGCST904699231.54e-05
11671CD27 levelsGCST904686151.53e-05
11672Waking up during the night and not easily going back to sleepGCST904763861.53e-05
11673Melanomas of skin (PheCode 172.11)GCST904755781.53e-05
11674Triglycerides in HDL (UKB data field 23410)GCST902695071.53e-05
11675Cholesterol to Total Lipids in Small HDL percentageGCST904993691.52e-05
11676Triglycerides x depression interaction (2df test)GCST905706791.51e-05
11677Cholesterol levels in chylomicrons and extremely large VLDLGCST900930401.50e-05
11678Concentration of chylomicrons and extremely large VLDL particlesGCST905010151.49e-05
11679PLA2G15 levelsGCST904702451.48e-05
11680Aspartate aminotransferase levelsGCST900187241.48e-05
11681Whiskey likingGCST900948731.48e-05
11682Omega-6 fatty acids levelsGCST904991771.47e-05
11683PSRC1/SORT1 ratioGCST903157421.47e-05
11684Triglycerides in LDL (UKB data field 23409)GCST902695061.47e-05
11685Free cholesterol to total lipids ratio in IDLGCST900928361.47e-05
11686Principal component-derived dietary pattern 16GCST901330211.47e-05
11687Cholesteryl ester levels in chylomicrons and extremely large VLDLGCST900930421.46e-05
11688Monounsaturated fatty acids to total fatty acids percentageGCST904991111.46e-05
11689Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009831.45e-05
11690Percentage of invited food questionnaires completedGCST900127901.45e-05
11691Poisoning by antibiotics | injuries & poisoningsUKBB000006531.43e-05
11692Linoleic acid levelsGCST905022941.43e-05
11693Varicose veins of lower extremity, symptomtic (PheCode 454.11)GCST904760141.43e-05
11694Average diameter for HDL particlesGCST901327021.42e-05
11695Cholesterol to total lipids in large HDL percentage (UKB data field 23635)GCST902697321.42e-05
11696TNFRSF6B levelsGCST904709141.42e-05
11697Saturated fatty acids to total fatty acids percentageGCST904999661.42e-05
11698Birth year infant mortality ratesGCST900950471.41e-05
11699METAP2/USP8 ratioGCST903154341.41e-05
11700Omega-6 fatty acid levelsGCST905025141.41e-05
11701SERPINB1/SERPINB9 ratioGCST903158271.41e-05
11702CD80 levelsGCST904686501.41e-05
11703SERPIND1 levelsGCST904705951.40e-05
11704Tyrosine levels (UKB data field 23469)GCST902695661.40e-05
11705Pain (limb, back, neck, head abdominally)FING000011351.40e-05
11706Triglycerides in small LDLGCST904997121.39e-05
11707LBR/PSRC1 ratioGCST903153001.39e-05
11708GCNT1 levelsGCST904693191.38e-05
11709EREG/HBEGF ratioGCST903147021.38e-05
11710sodium (minimum, inv-norm transformed)GCST904763971.38e-05
11711CES2 levelsGCST904687191.37e-05
11712Non-cancer illness code, self-reported - hypothyroidism/myxoedema | Medical conditionsUKBB000005181.36e-05
11713X-24544 levelsGCST902006361.36e-05
11714Triglycerides in large LDL (UKB data field 23536)GCST902696331.35e-05
11715Polyunsaturated fatty acid levelsGCST905026061.34e-05
11716DTI autoptx L2 cgc r tractGCST903851711.33e-05
11717Frontotemporal dementiaFING000005601.33e-05
11718Allergic contact dermatitisFING000000681.33e-05
11719Total lipids in small LDLGCST904996521.33e-05
11720Free Cholesterol to Total Lipids in Very Small VLDL percentageGCST905007911.32e-05
11721IGLC2 levelsGCST904695361.32e-05
11722Alanine levelsGCST900928061.32e-05
11723INSL5 levelsGCST904696221.31e-05
11724TNFRSF13C/TNFSF13B ratioGCST903159341.30e-05
11725ADGRE5/SEMA7A ratioGCST903131831.30e-05
11726aparc-a2009s rh thickness G+S-cingul-AntGCST900036821.29e-05
11727Degree of unsaturationGCST905001621.28e-05
11728NINJ1 levelsGCST904700491.28e-05
11729CANT1 levelsGCST904685361.27e-05
11730Ratio of bis-allylic bonds to double bonds in lipidsGCST901327441.26e-05
11731CD300E/EFNA4 ratioGCST903137971.26e-05
11732Eosinophil countGCST900259871.25e-05
11733Gout, strict definitionFING000005881.25e-05
11734Free cholesterol levels in VLDLGCST900929981.24e-05
11735Frequency of unenthusiasm / disinterest in last 2 weeks | Mental healthUKBB000002701.23e-05
11736LAYN/ULBP2 ratioGCST903152921.23e-05
11737Mean corpuscular hemoglobinGCST900023231.21e-05
11738Triglyceride levels in very large HDLGCST900930141.21e-05
11739DTI TBSS MD Anterior limb of internal capsule RGCST903845881.21e-05
11740Taking other prescription medications | MedicationUKBB000008131.21e-05
11741Thyroid peroxidase antibody positivity in pregnancyGCST904352021.19e-05
11742ITIH3 levelsGCST904696501.19e-05
11743Free cholesterol to total lipids ratio in very large VLDLGCST900930211.19e-05
11744PRSS8 levelsGCST904703451.19e-05
11745N6-methyllysine levels in chronic kidney diseaseGCST902575301.19e-05
11746FASLG levelsGCST904691911.18e-05
11747LEP levelsGCST904697571.17e-05
11748FETUB levelsGCST904692151.16e-05
11749NELL2/SEZ6L ratioGCST903155361.16e-05
11750eosinophil (absolute count, mean, inv-norm transformed)GCST904752911.15e-05
11751Total fatty acid levelsGCST905000611.15e-05
11752F9/RARRES2 ratioGCST903147491.14e-05
11753eosinophil (absolute count, minimum, inv-norm transformed)GCST904752941.14e-05
11754TNFRSF1B levelsGCST904709111.12e-05
11755Linoleic acid to total fatty acids percentageGCST905023361.11e-05
11756MAP4K5/TBCB ratioGCST903153841.11e-05
11757Cholesteryl esters in small HDL (UKB data field 23576)GCST902696731.11e-05
11758Phospholipids to Total Lipids in Very Small VLDL percentageGCST905008661.11e-05
11759Acute alcohol intoxication, ICD10FING000000151.11e-05
11760CREG1 levelsGCST904688571.11e-05
11761T1 FreeSurfer aseg Left-CaudateGCST903841441.10e-05
11762F-meat liking (derived food-liking factor)GCST900947991.10e-05
11763Feeling lonelyGCST0069421.10e-05
11764Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905010501.09e-05
11765Obesity due to excess caloriesFING000008961.09e-05
11766KLK11 levelsGCST900120121.09e-05
11767Plasma pregnenetriol disulfate* levels in chronic kidney diseaseGCST902658641.08e-05
11768LifespanGCST905518841.07e-05
11769LILRB1 levelsGCST904697761.06e-05
11770KLK14 levelsGCST904697001.05e-05
11771LGALS9 levelsGCST904697651.05e-05
11772SDC4/SELP ratioGCST903158171.05e-05
11773ASS1 levelsGCST904683801.04e-05
11774CLEC4G/LGALS4 ratioGCST903141201.04e-05
11775Phospholipids to total lipids ratio in medium LDLGCST900929131.03e-05
11776Linoleic acid levelsGCST905020041.02e-05
11777Eosinophil countGCST900187331.02e-05
11778CTSB levelsGCST904689081.01e-05
11779IL5RA levelsGCST904696001.01e-05
11780Recent feelings of depression | DepressionUKBB000007371.00e-05
11781Cholesterol to total lipids in large VLDL percentage (UKB data field 23590)GCST902696871.00e-05
11782Triglycerides to Total Lipids in Small HDL percentageGCST904995309.98e-06
11783Linoleic acid levelsGCST905023109.95e-06
11784Attendance/disability/mobility allowance - None of the above | Other sociodemographic factorsUKBB000000599.93e-06
11785Total lipid levels in small VLDLGCST900929749.88e-06
11786PollinosisGCST900186839.87e-06
11787Reason for reducing amount of alcohol drunk - Health precaution | AlcoholUKBB000007349.85e-06
11788Omega-3 fatty acids to total fatty acids percentageGCST904991559.82e-06
11789CLEC1A/TNFRSF1A ratioGCST903140859.78e-06
11790CKAP4/TNFRSF4 ratioGCST903140769.74e-06
11791Age when finished full-time education (standard GWA)GCST902672809.71e-06
11792SBSN levelsGCST904705319.70e-06
11793Triglycerides to total lipids in medium VLDL percentage (UKB data field 23598)GCST902696959.63e-06
11794SPINT1/SUSD2 ratioGCST903158789.61e-06
11795CA9 levelsGCST904685189.55e-06
11796Frailty (Factor 2 - Unhealthy Lifestyle)GCST906240489.53e-06
11797Allergy/adverse effect of penicillin | injuries & poisoningsUKBB000000289.52e-06
11798Triglycerides to total lipids ratio in medium HDLGCST900929039.47e-06
11799CALCOCO1/INPPL1 ratioGCST903136039.42e-06
11800IFI30 levelsGCST904695099.38e-06
11801LILRB2 levelsGCST904697779.34e-06
11802TNFRSF10B levelsGCST904709009.30e-06
11803Average diameter for HDL particlesGCST904974469.29e-06
11804Cholesterol levels in very small VLDLGCST905007009.27e-06
11805MMP9/OLR1 ratioGCST903154679.24e-06
11806Cholesterol esters in very small VLDLGCST905007409.20e-06
11807mean corpuscular hemoglobin concentration (MCHC, minimum, inv-norm transformed)GCST904754629.19e-06
11808CXCL5/SDC4 ratioGCST903143539.17e-06
11809TIA1/USP8 ratioGCST903159209.17e-06
11810CASP3/SNAP23 ratioGCST903136449.14e-06
11811lymphocyte (absolute count, minimum, inv-norm transformed)GCST904754299.13e-06
11812Phospholipid levels in VLDLGCST900930019.10e-06
11813T1 FreeSurfer BA lh BA3a exvivo thicknessGCST903855219.10e-06
11814Personal history of allergy to drugs, medicaments and biologocal substances | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB000006419.00e-06
11815Patient classification on admission (recoded) - Inpatient | Summary AdministrationUKBB000006378.96e-06
11816F2R/TNFRSF14 ratioGCST903147398.96e-06
11817FHIT/GLOD4 ratioGCST903148178.93e-06
11818HippSubfield lh volume CA4-headGCST900026828.92e-06
11819Triglycerides to Total Lipids in IDL percentageGCST904976828.92e-06
11820Principal component-derived dietary pattern 36GCST901330418.89e-06
11821Total free cholesterol levelsGCST900929888.87e-06
11822Linoleic acid levelsGCST900928808.84e-06
11823CD6/EZR ratioGCST903138908.82e-06
11824Phospholipid levels in very large HDLGCST901326428.80e-06
11825Lymphocyte percentage of white cellsGCST0046328.74e-06
11826SMNDC1 levelsGCST904706818.71e-06
11827Provencibacterium abundance in stoolGCST900325288.70e-06
11828Treatment/medication code - ventolin 100micrograms inhaler | MedicationsUKBB000008608.69e-06
11829Prescriptions - antispasmodicUKBB000006668.56e-06
11830CDKN1A/HBEGF ratioGCST903139728.55e-06
11831PCSK7 levelsGCST904701768.52e-06
11832eosinophil (fraction, maximum, inv-norm transformed)GCST904752978.46e-06
118331-ribosyl-imidazoleacetate levelsGCST901998158.35e-06
11834KLK8/NECTIN4 ratioGCST903152588.32e-06
11835Any mental disorderFING000001008.31e-06
11836THPO levelsGCST904708578.31e-06
11837EBAG9/TGFB1 ratioGCST903145708.22e-06
11838KLK8 levelsGCST904697078.20e-06
11839Propionylglycine levelsGCST901997058.15e-06
11840Beef/steak likingGCST900947008.12e-06
11841ITGB7 levelsGCST904696478.09e-06
11842LAMP2 levelsGCST904697348.07e-06
11843Cholesterol levels in small HDLGCST900929448.06e-06
11844Triglycerides to Total Lipids in Large VLDL percentageGCST904982938.05e-06
11845TNFSF10 levelsGCST904709178.03e-06
11846Linoleic acid levelsGCST905023067.99e-06
11847MARCO levelsGCST904698617.99e-06
11848RASSF2 levelsGCST904704317.96e-06
11849Concentration of small HDL particlesGCST904994617.91e-06
11850BBQ/grilled meat likingGCST900946987.90e-06
11851Linoleic acid levelsGCST904983067.86e-06
11852Irritable bowel syndromeGCST902439587.79e-06
11853Cholesterol to total lipids in medium LDL percentage (UKB data field 23620)GCST902697177.78e-06
11854CST3/IL18BP ratioGCST903142947.69e-06
11855Dermatophytosis (PheCode 110.1)GCST904755617.66e-06
11856LGALS4 levelsGCST904697627.63e-06
11857ST6GAL1 levelsGCST904707537.56e-06
11858High light scatter reticulocyte percentage of red cellsGCST0046127.49e-06
11859Other degenerative diseases of the nervous systemFING000009947.44e-06
11860Other soft tissue disorders, not elsewhere classifiedFING000010997.41e-06
11861Frequency of walking for pleasure in last 4 weeks | Physical activityUKBB000002717.41e-06
11862CCL23 levelsGCST904685757.38e-06
11863Cholesterol to Total Lipids in Medium LDL percentageGCST904987147.37e-06
11864Mean corpuscular volumeGCST900023357.24e-06
11865KLRB1 levelsGCST904697097.23e-06
11866FGF21/LEP ratioGCST903148107.22e-06
11867Own or rent accommodation lived in - Rent - from local authority, local council, housing association | HouseholdUKBB000006247.15e-06
11868DTI TBSS L1 Anterior corona radiata LGCST903844517.07e-06
11869Hypercalcemia (PheCode 275.6)GCST904757487.05e-06
11870Gestational age at birth (maternal effect)GCST902684197.05e-06
11871Types of physical activity in last 4 weeks - None of the above | Physical activityUKBB000008727.04e-06
11872Phospholipids in small VLDLGCST904998816.95e-06
11873Atopic/contact dermatitis due to other or unspecified (PheCode 939)GCST904762896.94e-06
11874Monounsaturated fatty acid levelsGCST905020386.92e-06
11875DAPP1/PTPN6 ratioGCST903143976.90e-06
11876Total lipid levels in VLDLGCST900929996.88e-06
11877PDCD1/TNFRSF4 ratioGCST903156096.88e-06
11878C19ORF12 levelsGCST904684836.86e-06
11879Phospholipids to Total Lipids in Large HDL percentageGCST904978686.82e-06
11880Phospholipids to Total Lipids in Medium LDL percentageGCST904988526.76e-06
11881Cholesteryl Esters in Large LDLGCST904979496.65e-06
11882Bifidobacterium kashiwanohense abundance in stoolGCST900322266.63e-06
11883CD7 levelsGCST904686496.61e-06
11884CEP43/USP8 ratioGCST903140226.57e-06
11885Concentration of very small VLDL particlesGCST905008266.52e-06
11886T1 FreeSurfer aseg Right-CaudateGCST903841626.52e-06
11887Tyrosine levelsGCST900929936.45e-06
11888Physical activity (Total log acceleration 6pm-8pm)GCST900614186.43e-06
11889Monounsaturated fatty acid levelsGCST905020306.41e-06
11890CD22/TCL1A ratioGCST903137606.40e-06
11891ERBB2/GUSB ratioGCST903146876.37e-06
11892RRM2 levelsGCST904705016.36e-06
11893Omega-6 fatty acids to total fatty acids percentageGCST905025296.33e-06
11894Other and unspecified tonsillitisFING000009546.31e-06
11895VCAM1 levelsGCST904710316.23e-06
11896CD300E/CD59 ratioGCST903137946.21e-06
11897Principal component-derived dietary pattern 24GCST901330296.17e-06
11898Nontoxic goitre/thyroid noduleFING000008876.15e-06
11899SERPINC1 levelsGCST904705946.15e-06
11900DCXR/SCLY ratioGCST903144406.14e-06
11901HypothyroidismGCST902041676.14e-06
11902CLEC4G/KDR ratioGCST903141186.12e-06
11903Total lipids in large HDLGCST904978186.08e-06
11904Dermatophytosis / Dermatomycosis (PheCode 110)GCST904755606.04e-06
11905DTI TBSS MD Anterior limb of internal capsule LGCST903845896.01e-06
11906MS-disease / Multiple SclerosisFING000008395.98e-06
11907Total lipid levels in lipoprotein particlesGCST905000855.98e-06
11908Concentration of large HDL particlesGCST904978365.96e-06
11909LPO levelsGCST904697895.95e-06
11910HPCAL1/SERPINB9 ratioGCST903150795.94e-06
11911Rubneribacter sp002159915 abundance in stoolGCST900325415.92e-06
11912CSF1 levelsGCST904688815.88e-06
11913Cholesteryl Esters in Small HDLGCST904993865.86e-06
11914PDCD1 levelsGCST904701815.83e-06
11915CDC37/SNX9 ratioGCST903139365.70e-06
11916Other Crohn's diseaseFING000009925.68e-06
11917Total fatty acid levelsGCST905027225.66e-06
11918Blood cell traits latent factor 17 (white cell)GCST905592595.66e-06
11919F11R/TMSB10 ratioGCST903147295.55e-06
11920eosinophil (fraction, minimum, inv-norm transformed)GCST904753035.54e-06
11921N-delta-acetylornithine levelsGCST902006915.51e-06
11922CPM/LAMP2 ratioGCST903142155.47e-06
11923GP1BA/SIAE ratioGCST903149595.37e-06
11924Ratio of saturated fatty acids to total fatty acidsGCST900929815.33e-06
11925Seborrhoeic dermatitisFING000012825.31e-06
11926F-dessert liking (derived food-liking factor)GCST900947545.29e-06
11927Total fatty acid levelsGCST905027265.20e-06
11928Pain type(s) experienced in last month - Pain all over the body | PainUKBB000006325.17e-06
11929CALCOCO1/METAP2 ratioGCST903136065.13e-06
11930Omega-3 fatty acid levelsGCST905024225.09e-06
11931Mean reticulocyte volumeGCST900259755.08e-06
11932Glycated haemoglobin HbA1c levels (UKB data field 30750)GCST904680725.02e-06
11933Types of physical activity in last 4 weeks - Other exercises (eg: swimming, cycling, keep fit, bowling) | Physical activityUKBB000008735.01e-06
11934Triglycerides to total lipids ratio in very small VLDLGCST900930395.01e-06
11935Croissant likingGCST900947485.00e-06
11936Triglyceride levels in small HDLGCST900929544.99e-06
11937mean corpuscular hemoglobin (MCH, minimum, inv-norm transformed)GCST904754504.97e-06
11938Mean corpuscular volume (UKB data field 30040)GCST904680864.94e-06
11939Cholesteryl ester levels in small HDLGCST900929464.91e-06
11940Lichen simplex chronicus and prurigoFING000007254.91e-06
11941Linoleic acid to total fatty acids percentage (UKB data field 23456)GCST902695534.90e-06
11942Total Lipids in LDLGCST904983964.89e-06
11943Total fatty acid levelsGCST905000534.83e-06
11944CRTAM/ICAM3 ratioGCST903142764.82e-06
11945Colon cancer/rectal cancerGCST904751704.81e-06
11946Type1 diabetes, definitions combined, early onsetFING000013844.80e-06
11947ALDH1A1/PKLR ratioGCST903132454.77e-06
11948Cholelithiasis and cholecystitis | digestiveUKBB000001334.75e-06
11949CD40/ITGB5 ratioGCST903138164.63e-06
11950GALNT10/SEMA7A ratioGCST903149154.61e-06
11951Treatment or medication use - levothyroxine sodium (UKB data field 20003_1141191044)GCST900425354.61e-06
11952SLAMF1 levelsGCST904706494.58e-06
11953Reason for glasses/contact lenses - For 'astigmatism' | EyesightUKBB000007334.55e-06
11954CD84/SDC4 ratioGCST903139164.53e-06
11955ACE2 levelsGCST904681974.51e-06
11956TNFSF11 levelsGCST902748444.51e-06
11957BLNK levelsGCST904684484.48e-06
11958eosinophil (fraction, mean, inv-norm transformed)GCST904753004.46e-06
11959IFNAR1 levelsGCST904695124.41e-06
11960TCN2 levelsGCST904708204.38e-06
11961Cholesterol to total lipids ratio in large LDLGCST900928574.37e-06
11962PRCP levelsGCST904703144.37e-06
11963CA13/TYMP ratioGCST903135684.36e-06
11964Basophil countGCST900022924.31e-06
11965SDC4/SERPINE1 ratioGCST903158194.30e-06
11966GZMB levelsGCST904694244.30e-06
11967Glycated haemoglobin (HbA1c) | Blood biochemistryUKBB000002894.28e-06
11968Saturated fatty acids levelsGCST905026704.26e-06
11969CD5/IL16 ratioGCST903138614.22e-06
11970Phospholipids in small HDL (UKB data field 23574)GCST902696714.21e-06
11971Red wine consumption (glasses per month) (UKB data field 1578, 4419)GCST901329874.16e-06
11972Rash and other nonspecific skin eruption (PheCode 687.1)GCST904761674.14e-06
11973Omega-6 fatty acids to total fatty acids percentageGCST905025284.13e-06
11974Takes medication for migraine headaches?GCST904755474.09e-06
11975Monounsaturated fatty acid levelsGCST905023624.07e-06
11976EREG/GYS1 ratioGCST903147014.06e-06
11977ITGAL levelsGCST904696374.05e-06
11978TGFB1 levelsGCST902748184.05e-06
11979HBEGF/PDGFA ratioGCST903150334.04e-06
11980Saturated fatty acids levelsGCST905026584.04e-06
11981TFRC levelsGCST904516843.99e-06
11982CFI levelsGCST904687303.98e-06
11983Omega-3 fatty acid levelsGCST905020613.98e-06
11984lymphocyte (fraction, minimum, inv-norm transformed)GCST904754383.91e-06
11985CD86 levelsGCST904686543.88e-06
11986Basophil count varianceGCST905656823.86e-06
11987CD22 levelsGCST904686103.80e-06
11988Poultry consumptionGCST901329963.80e-06
11989Basophil countGCST900023793.77e-06
11990Seborrheic dermatitis (PheCode 690.1)GCST904761713.76e-06
11991Triglycerides to Total Lipids in Very Large HDL percentageGCST905005063.76e-06
11992REG1A/TFF3 ratioGCST903157643.72e-06
11993BAG6/BMP6 ratioGCST903134503.63e-06
11994FADD/PLIN3 ratioGCST903147723.58e-06
11995HIP1R levelsGCST904694533.52e-06
11996PLAUR levelsGCST904702513.47e-06
11997CD300A levelsGCST904686193.45e-06
11998Erythematous conditions (PheCode 695)GCST904761773.37e-06
11999Coffee intake (standard GWA)GCST902672743.33e-06
12000Cholesterol to total lipids in small LDL percentage (UKB data field 23625)GCST902697223.32e-06